SNDX FY 2019 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

SNDXSyndax Pharmaceuticals, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+0.0% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$58M-3792.9% margin

Net Income

-$56M-3688.5% margin

EPS (Diluted)

$-1.84

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$51M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$64M

Total Liabilities

$32M

Stockholders' Equity

$32M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+0.0%
Gross Profit	$2M	$2M	+0.0%
Operating Income	-$58M	-$76M	+24.2%
Net Income	-$56M	-$74M	+24.3%